Tussigon
- Generic Name: hydrocodone bitartrate and homatropine methylbromide tablets
- Brand Name: Tussigon
Tussigon (Hydrocodone Bitartrate and Homatropine Methylbromide Tablets) side effects drug center
- Related Drugs
- sedation,
- drowsiness,
- mental clouding,
- lethargy,
- impairment of mental and physical performance,
- anxiety,
- fear,
- uneasiness,
- dizziness,
- psychic dependence,
- mood changes,
- nausea,
- vomiting,
- constipation,
- urinary retention,
- respiratory depression,
- skin rash, and
- itching.
- noisy breathing, sighing, shallow breathing;
- extreme drowsiness, confusion, feeling weak or limp;
- a seizure;
- a light-headed feeling, like you might pass out;
- severe constipation, stomach pain;
- little or no urination;
- adrenal gland problems--nausea, vomiting, loss of appetite, dizziness, worsening tiredness or weakness; or
- high levels of serotonin in the body--agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, diarrhea.
- drowsiness, dizziness;
- lack of energy, coordination problems;
- headache, confusion;
- dry mouth, nausea, vomiting, constipation;
- tremors, fast or irregular heart rate; or
- feeling anxious, restless, nervous, or irritable.
Tussigon Tablets (hydrocodone bitartrate and homatropine methylbromide) is a combination of a narcotic cough medicine and a medicine that works against the narcotic to prevent an overdose used to treat cough. Common side effects of Tussigon include:
The adult dose of Tussigon is one (1) tablet every 4 to 6 hours as needed; do not exceed six (6) tablets in 24 hours. The dose of Tussigon for children 6 to 12 years of age is one-half (1/2) tablet every 4 to 6 hours as needed; do not exceed three (3) tablets in 24 hours. Tussigon may interact with narcotics, antihistamines, antipsychotics, antianxiety agents, other CNS depressants (including alcohol), MAO inhibitors, and tricyclic antidepressants. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Tussigon; it is unknown how it will affect a fetus. Babies born to mothers who have been taking opioids such as hydrocodone in Tussigon regularly prior to delivery will be physically dependent. It is unknown if Tussigon passes into breast milk. Breastfeeding while using Tussigon is not recommended. Withdrawal symptoms may occur if you suddenly stop taking Tussigon.
Our Tussigon Tablets (hydrocodone bitartrate and homatropine methylbromide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Opioid medicine can slow or stop your breathing, and death may occur. A person caring for you should give naloxone and/or seek emergency medical attention if you have slow breathing with long pauses, blue colored lips, or if you are hard to wake up.
Stop taking this medicine and call your doctor at once if you have:
Serious breathing problems may be more likely in older adults and in those who are debilitated or have wasting syndrome or chronic breathing disorders.
Common side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Tussigon (Hydrocodone Bitartrate and Homatropine Methylbromide Tablets)
SIDE EFFECTS
Central Nervous System
Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, dizziness, psychic dependence, mood changes.
Gastrointestinal System
Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients.
Prolonged administration of TUSSIGON may produce constipation.
Genitourinary System
Ureteral spasm, spasm of vesicle sphincters and urinary retention have been reported with opiates.
Respiratory Depression
TUSSIGON may produce dose-related respiratory depression by acting directly on brain stem respiratory centers (see OVERDOSE).
Dermatological
Skin rash, pruritus.
Read the entire FDA prescribing information for Tussigon (Hydrocodone Bitartrate and Homatropine Methylbromide Tablets)
© Tussigon Patient Information is supplied by Cerner Multum, Inc. and Tussigon Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.